Rheumatoid Arthritis Market and Epidemiology Forecast 2024-2034 Featuring Analysis of ATI-450 (Aclaris Therapeutics) and Olumiant/Baricitinib (Eli Lilly/Incyte)
June 25, 2024 12:36 ET
|
Research and Markets
Dublin, June 25, 2024 (GLOBE NEWSWIRE) -- The "Rheumatoid Arthritis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report has been added to ...
US Rheumatoid Arthritis Market and Competitive Landscape Report 2021-2026: Pipeline Products, Epidemiology, Market Valuations and Forecasts, Drugs Sales
May 31, 2021 07:38 ET
|
Research and Markets
Dublin, May 31, 2021 (GLOBE NEWSWIRE) -- The "US Rheumatoid Arthritis Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. US Rheumatoid Arthritis...
Global Rheumatoid Arthritis Clinical Trial Pipeline Report 2021: Clinical Trial Stages, Drug Mechanism Classes, Companies, Short-term Launch Highlights
May 28, 2021 08:33 ET
|
Research and Markets
Dublin, May 28, 2021 (GLOBE NEWSWIRE) -- The "Global Rheumatoid Arthritis Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering. Rheumatoid Arthritis...
Novel Rheumatoid Arthritis drugs succeed in the clinical trials: A status report by DelveInsight
March 18, 2021 21:30 ET
|
DelveInsight Business Research LLP
Los Angeles, USA , March 18, 2021 (GLOBE NEWSWIRE) -- Novel Rheumatoid Arthritis drugs succeed in the clinical trials: A status report by DelveInsight The Rheumatoid Arthritis Pipeline is robust as...